| Financial Year |
March 31 2023 |
| Monetary Funds |
313,777,829.27 |
| Held-for-trading Financial Assets |
158,660,000.00 |
| Notes Receivable |
17,652,033.93 |
| Accounts Receivable |
133,576,810.62 |
| Advances to Suppliers |
21,094,293.40 |
| Other Receivables |
13,699,092.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
278,878,170.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,405,539.30 |
| Total Current Assets |
1,006,716,374.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,616,034.69 |
| Fixed Assetes |
377,104,009.50 |
| Under-construction Projects |
607,019,128.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
215,508,271.98 |
| R&D expenses |
54,266,752.10 |
| Goodwill |
76,226,184.16 |
| Long-Term Deferred and Prepaid Expenses |
4,574,502.78 |
| Deferred Income Tax Assets |
96,148,246.97 |
| Other Non-Current Assets |
17,331,199.35 |
| Sub-Total of Non-Current Assets |
1,571,617,802.02 |
| Total Assets |
2,578,334,176.95 |
| Short-Term Loans |
31,981,454.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,521,510.62 |
| Accounts Payable |
141,937,228.67 |
| Accounts Received In Advance |
629,160.38 |
| Employee Compensation Payable |
44,862,348.09 |
| Taxes Payable |
2,908,910.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,930,950.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,389,326.95 |
| Other Current Liabilities |
1,065,315.69 |
| Sub-Total of Current Liabilities |
381,578,495.83 |
| Long-term Loans |
246,796,407.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
95,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,239,207.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
391,450,438.36 |
| Total Liabilities |
773,028,934.19 |
| Paid-In Capital(Or Share Stock) |
517,636,745.00 |
| Capital Surplus |
1,081,122,484.95 |
| Surplus Reserve |
40,824,422.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
172,151,319.97 |
| Minority Stockholder's Interest |
-8,163,372.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,813,468,615.36 |
| Owner's Equity（Stockholder's Equity） |
1,805,305,242.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,578,334,176.95 |
